id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345095-1li57v0j	Felix, Carol	Clinical Research in the Time of COVID-19	2020-10-01		.txt	text/plain	1242	74	57	The need for clinical trials, the improved treatments they elucidate, and the US Food and Drug Administration (FDA) approval providing public access to these new and better treatments will remain. The pandemic does not end medical research, and it may, in fact, point us in a new and better direction for implementing clinical trials. 1 Academic institutions will do robust research again, and those institutions most prepared to pick up research at prepandemic levels will be those that follow FDA guidelines to facilitate and continue running clinical trials even during the spread of COVID-19. So, how do we run clinical trials in the time of COVID-19? Until a vaccine is developed, and likely even after that if COVID-19 becomes a seasonal norm, we will have to weigh the risks and benefits of everything we do, including medical visits and research appointments. FDA Guidance on conduct of clinical trials of medical products during COVID-19 public health emergency: guidance for industry, investigators, and institutional review boards	./cache/cord-345095-1li57v0j.txt	./txt/cord-345095-1li57v0j.txt